Searched for
CHINA MEDICINE POLICIES
'No Americans qualified': University of Michigan faces heat over $75,000 H-1B techie roles; critics question hiring of foreign workersH1-B row: The University of Michigan has sparked an online storm over H-1B visa job postings for tech roles. Independent journalist Chris B...
Trade disruptions, API dependence, compliance costs: Pharma MSMEs spell out policy priorities on World MSME DayIndian pharmaceutical MSMEs are facing immense pressure from rising costs, supply chain woes, and stringent regulations. Industry represent...
India, Russia prevented global economy from collapsing: IMEMO chiefRussia and India have forged a new global economic model, preventing global collapse and aiding the Global South with affordable resources....
India needs to remain attractive for innovation-led investment: Judith Love, NovartisWith an eye on India's blossoming market, Novartis is set to launch pioneering therapies, including radioligand and gene therapies. The com...
Japanese investors are looking beyond China... India is key alternative: Tsutomu Takemura, Senior MD, NomuraIndia is increasingly becoming a long-term structural investment destination rather than a short-term strategic bet. Global capital is movi...
How Canada's draft chatbot law stacks up on global sceneCanada's proposed law requiring chatbot providers to protect users from "harmful" content is the latest step by global governments to regul...
Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
China’s EV boom is cleaning the air, and may have prevented 262,000 deathsElectric vehicles are proving to be life savers. Studies show China's shift to electric cars has prevented thousands of premature deaths. A...
India's biggest trade bet comes with six red flagsIndia may be adding more trade partners, but its latest FTA report card comes with several red marks. A new study by the Global Trade Resea...
Root cause: India’s spice crown under threat as quality concerns trace back to farmsFarm-level traceability, quality, value addition, and branding are key to converting export scale into global trust, according to experts.
US visa laws do not target India; H-1B rules part of global framework, clarifies State Dept officialA senior US State Department official stated that US visa laws are applied uniformly across all countries, including India, dispelling conc...
US optimistic about progress in trade talks with India; deal a priority: State DeptThe US is optimistic about trade negotiations with India, with a bilateral trade deal remaining a priority for the Trump administration. St...
View: US-India relations need more than Trump calls and warm wordsMarco Rubio's visit aimed to mend US-India ties, emphasizing strategic importance amid political challenges. While progress was noted in ar...
More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
From oncology to obesity, Pfizer bets big on India for its next growth wavePfizer is prioritizing India for future growth. The company plans to launch new medicines here soon after their global release. Pfizer aims...
A Rs 3 hike makes India’s inflation battle somewhat harderIndian Oil Marketing Companies have increased petrol and diesel prices by Rs 3 per litre each, and CNG by Rs 2/kg, following daily losses o...
These large- mid- and small-cap stocks have an upside potential of up to 31% in 1 year, according to analystsAs nothing can be ruled out on the street, be prepared for anything. Now, what is the probability that the bears will be chased away from t...
Soaring inflation and plummeting economy test Iran's ability to withstand war and US blockadeIran faces severe economic hardship due to war and US sanctions. Prices for essentials like food and medicine have surged. Job losses and b...
AstraZeneca plans to invest $405 million in Britain, PM Keir Starmer saysPrime Minister Keir Starmer announced AstraZeneca will invest 300 million pounds in UK life sciences. This significant investment secures 1...
China to 'refine' centralized medicine procurement policiesChina will refine its centralized drug procurement policy following a probe into off-patent medicine quality, aiming to enhance evaluations...